Systemic Lupus

13 registered clinical trials studyying Systemic Lupus — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases NCT06435468	Hospices Civils de Lyon	N/A
Terminated	Immune Response to SARS-CoV-2 Vaccination in Systemic Lupus NCT04894253	University Hospital, Strasbourg, France	—
Unknown	Serum Ceramides Level in Systemic Lupus Erythematosus (SLE) Patients as a Novel Marker for Renal Impairment NCT04256577	Assiut University	—
Unknown	SSerum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus Nephritis NCT03164720	Assiut University	—
Unknown	Chemokine (CXCL13) as Anew Marker in Diagnosis of SLE NCT03752983	Assiut University	—
Completed	Immune Adsorption Role in Treatment of Resistant Lupus NCT04108611	Dr. Mohamed Ahmed El ghiriani	N/A
Completed	ASA Patterns for Prevention of Preeclampsia in SLE Pregnancies NCT03749044	McGill University Health Centre/Research Institute of the McGill University Health Centre	N/A
Completed	Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic Diseases NCT03540823	University of Sao Paulo General Hospital	Phase 4
Unknown	Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH) NCT03819777	Maastricht University Medical Center	—
Completed	Yellow Fever Vaccine in Patients With Rheumatic Diseases NCT03430388	University of Sao Paulo General Hospital	N/A
Completed	Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease NCT03762824	Region Skane	Phase 4
Completed	Use of Social Media to Improve Medication Adherence in Adolescents and Young Adults With Systemic Lupus NCT03218033	Milton S. Hershey Medical Center	N/A
Terminated	Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC) NCT01738360	Nantes University Hospital	Phase 2